1. Home
  2. AVDL vs CXM Comparison

AVDL vs CXM Comparison

Compare AVDL & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$7.71

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
CXM
Founded
2015
2009
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AVDL
CXM
Price
$21.63
$7.71
Analyst Decision
Buy
Hold
Analyst Count
9
9
Target Price
$18.38
$9.89
AVG Volume (30 Days)
2.1M
2.5M
Earning Date
11-04-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
180.38
EPS
N/A
0.42
Revenue
$248,517,000.00
$839,147,000.00
Revenue This Year
$65.47
$8.25
Revenue Next Year
$30.88
$3.44
P/E Ratio
N/A
$18.16
Revenue Growth
79.88
6.48
52 Week Low
$6.38
$6.75
52 Week High
$23.57
$9.69

Technical Indicators

Market Signals
Indicator
AVDL
CXM
Relative Strength Index (RSI) 61.54 51.18
Support Level $21.36 $7.61
Resistance Level $21.68 $7.98
Average True Range (ATR) 0.12 0.19
MACD -0.12 -0.02
Stochastic Oscillator 74.68 19.17

Price Performance

Historical Comparison
AVDL
CXM

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: